Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and Colonoscopy in Elderly Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorHarbin Medical University

About this trial

The objective of this clinical trial is to assess the feasibility of the remimazolam combined with esketamine OFA (opioid-free anesthesia) protocol for painless gastroscopy and colonoscopy in elderly patients and to determine if it is non-inferior to the traditional OA (opioid-containing anesthesia) protocol. The main questions it aims to answer are:

* Is the remimazolam combined with esketamine protocol feasible for painless gastroscopy and colonoscopy in elderly patients? * Is the OFA protocol superior to the OA protocol?

Participants will:

* During anesthesia induction, the experimental group will receive remimazolam combined with esketamine for anesthesia, while the control group will receive remimazolam combined with remifentanil. * Record respiratory and circulatory indicators and adverse reaction times.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing painless gastroenteroscopy in outpatient clinics;

aged 65 years and above;

American Society of Anesthesiologists (ASA) grades I - III.

Disqualifiers

Patients with abnormal liver or kidney function;

known respiratory or endocrine diseases;

Patients with uncontrolled hypertension and NYHA classification Ⅲ-Ⅳ;

Taking monoamine oxidase inhibitors, sedatives, analgesics, hypnotics, antipsychotics, antiemetics or antidepressants;

Trial design

Design model

Parallel

Treatments tested in this trial

  • remimazolam-remifentanil

    Combination product

    For elderly patients scheduled for elective painless gastro-intestinal endoscopy, remimazolam 0.2mg/kg and remifentanil 0.2ug/kg are used for anesthesia induction. During the operation, the doses are adjusted according to the depth of sedation of the patients.

  • remimazolam-esketamine

    Combination product

    For elderly patients scheduled for painless gastroenterological endoscopy, remimazolam 0.2mg/kg and esketamine 0.15mg/kg are used for anesthesia induction. During the operation, the dosage is adjusted according to the patient's level of sedation.

Treatment groups

280 Participants
are divided into 2 treatment groups
Group A: remimazolam plus esketamine groupExperimental treatment 1 intervention
Group B: remimazolam plus remifentanil groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Sedation success rate

Successful sedation:① The patient underwent painless gastroenteroscopy;②During anesthesia induction, a single remazolam is not enough to achieve sufficient sedation depth, and it needs to be remedied, and the number of remediations within 15min is less than 5 times; Intraoperative supplementary times ≤5 times within any 15min.③ The patient did not use rescue drugs;Sedation success rate: Number of patients successfully sedated/total number of patients included in the data analysis for this group

Time frame
From the start of anesthesia induction to the end of the surgery
2

Incidence of hypotension

Hypotension: systolic blood pressure below 80% of baseline systolic blood pressure or MAP below 80% of baseline MAP; Incidence of hypotension: Number of patients with intraoperative hypotension/total number of patients included in the data analysis for this group

Time frame
From the start of anesthesia induction to the end of the surgery

Secondary outcomes

1

degree of blood oxygen saturation

The blood oxygen saturation was recorded every 2 minutes during the operation. The maximum value is 100. An event where blood oxygen saturation drops below 90 is described as respiratory depression.

Time frame
From the start of anesthesia induction to the end of the surgery
2

respiratory rate

The respiratory rate was recorded every 2 minutes during the operation. The normal breathing rate is 12 to 20 breaths per minute.

Time frame
From the start of anesthesia induction to the end of the surgery
3

bispectral index

During the surgery, the bilateral frequency index of brain electricity was recorded every 2 minutes. The bispectral index of electroencephalogram is mainly used to assess the depth of sedation, the effect of anesthesia and the state of consciousness. Its value range is from 0 to 100. The higher the value, the higher the degree of consciousness; the lower the value, the deeper the degree of brain inhibition.

Time frame
From the start of anesthesia induction to the end of the surgery
4

Heart rate

The heart rate was recorded every 2 minutes during the operation. The normal heart rate is 60 to 100 beats per minute.

Time frame
From the start of anesthesia induction to the end of the surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Harbin Medical University

Lead sponsor

First Affiliated Hospital of Harbin Medical University

Collaborator